Cancer Family
Malignant Genitourinary System Neoplasm
CI-CAN-00000233Explore in graph →
3,546 active trials61 approved drugs295 evidence items
- NCIt
- C156484
Loading cancer entity…
Cancer Family
CI-CAN-00000233Explore in graph →
Clinical trials
15,539 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,963)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06536725 | Observation of Clinical Consistency of Organoid-chips Drug Sensitivity in Chemotherapy for PCa With Visceral Metastasis | unknown | — | 35 | Tianjin Medical University Second HospitalOTHER | 1 | Aug 5, 2024 | clinicaltrials |
| NCT06536855 | Faster Elimination of HPV Infection and Cervical Cancer Using Concomitant HPV Vaccination and HPV Screening: A Demonstration Project in Rwanda | unknown | Phase 4 | 100,000 | Rwanda Biomedical CentreOTHER | 0 | Aug 5, 2024 |
| clinicaltrials |
| NCT06533709 | Satisfactory Debulking Prediction Model for Advanced Ovarian Cancer Based on PET-CT Image Data | unknown | — | 146 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Aug 1, 2024 | clinicaltrials |
| NCT03366051 | Sentinel Node Mapping in High Risk Endometrial Cancer(ALICE) | unknown | N/A | 178 | AC Camargo Cancer CenterOTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT05822934 | Carboplatin-gemcitabine Versus Cisplatin- Gemcitabine as Neoadjuvant Chemotherapy for Treatment of Muscle Invasive Urinary Bladder Cancer | unknown | Phase 3 | 20 | Assiut UniversityOTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT06515678 | Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension(IATRO) | unknown | — | 9,464 | Groupe Hospitalier Pitie-SalpetriereOTHER | 1 | Jul 26, 2024 | clinicaltrials |
| NCT06521684 | Translational Study of MSS, TP53 Mutation and Chromosome Instability Relationship in Endometrial Carcinoma | unknown | — | 110 | Peking Union Medical College HospitalOTHER | 0 | Jul 26, 2024 | clinicaltrials |
| NCT05554276 | Neoadjuvant Chemotherapy Combined With PD-1 + Radical Radiotherapy in Locally Advanced Cervical Cancer(PD-1) | unknown | Phase 2 | 36 | Shanghai Jiao Tong University Affiliated Sixth People's HospitalOTHER | 1 | Jul 25, 2024 | clinicaltrials |
| NCT06237491 | The Safety and Dosimetry Study of 177Lu-LNC1003 Injection | unknown | Phase 1 | 12 | Yantai LNC Biotechnology Singapore PTE. LTD.INDUSTRY | 0 | Jul 24, 2024 | clinicaltrials |
| NCT04503148 | Anesthesia and Cancer Study: Renal Cell Carcinoma | unknown | N/A | 562 | Seoul National University HospitalOTHER | 1 | Jul 23, 2024 | clinicaltrials |
| NCT06516276 | Technologies to Improve QoL of Prostate Cancer(MIO) | unknown | N/A | 98 | Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat ValencianaOTHER | 0 | Jul 23, 2024 | clinicaltrials |
| NCT05013099 | Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies(iPREDICT) | unknown | Phase 2 | 70 | ImaginAb, Inc.INDUSTRY | 6 | Jul 22, 2024 | clinicaltrials |
| NCT05776693 | Relationships Among Physical and Psychological Status, Social Support, Resource Utilization, Supportive Care Needs in Patients With Gynecological Cancer | unknown | — | 200 | National Taiwan University HospitalOTHER | 1 | Jul 22, 2024 | clinicaltrials |
| NCT03362801 | SArcopenia, Mobility, PHYsical Activity and Post-operative Risk of Bladder Carcinoma in the Elderly(SAMPHYR) | unknown | N/A | 69 | University Hospital, CaenOTHER | 1 | Jul 19, 2024 | clinicaltrials |
| NCT06509529 | The Effect of Motivational Interviewing Based on the COM-B Model | unknown | N/A | 68 | Ordu UniversityOTHER | 0 | Jul 19, 2024 | clinicaltrials |
| NCT03614689 | Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire | unknown | — | 104 | Geneplus-Beijing Co. Ltd.INDUSTRY | 1 | Jul 18, 2024 | clinicaltrials |
| NCT06504017 | FUS-TB VS COG-TB in Small Lesions of Prostate Cancer | unknown | N/A | 200 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 0 | Jul 16, 2024 | clinicaltrials |
| NCT05675787 | Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia | unknown | Phase 2 | 82 | Peking University People's HospitalOTHER | 1 | Jul 11, 2024 | clinicaltrials |
| NCT05613738 | 177Lu-PSMA-EB-01 in Patients With Metastatic Castration-resistant Prostate Cancer | unknown | N/A | 9 | Peking Union Medical College HospitalOTHER | 1 | Jul 10, 2024 | clinicaltrials |
| NCT03079323 | Trial to Investigate the Benefit of Elective Para-Aortic Radiotherapy (PART) for pN1 Prostate Cancer(PART) | unknown | Phase 2 | 137 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT03080116 | Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomy(ARNEO) | unknown | Phase 2 | 90 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT03327675 | High Precision Imaging of Prostate Specific Membrane Antigen for Personalized Treatment in Prostate Cancer | unknown | N/A | 188 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT03340376 | Doxorubicin Alone Versus Atezolizumab Alone Versus Doxorubicin and Atezolizumab in Recurrent Cervical Cancer | unknown | Phase 2 | 48 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT03819751 | MRI-targeted Biopsy of the Prostate: Software Versus Visual Registration in the Accuracy of Prostate Cancer Detection(PROSOVI) | unknown | N/A | 96 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT05610501 | Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses. | unknown | — | 200 | Universitaire Ziekenhuizen KU LeuvenOTHER | 4 | Jul 3, 2024 | clinicaltrials |
| NCT05847348 | 68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients | unknown | Phase 3 | 110 | Telix Pharmaceuticals (Innovations) Pty LimitedINDUSTRY | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06484361 | PET/MRI to Stage Prostate Cancer Patients | unknown | Phase 2 | 50 | IRCCS San RaffaeleOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06456112 | Construction and Validation of a Diagnostic Model for Predicting Molecular Residual Disease and Recurrence of Cervical Cancer Based on Circulating Tumor HPV | unknown | — | 83 | Anhui Provincial HospitalOTHER_GOV | 1 | Jul 1, 2024 | clinicaltrials |
| NCT04432857 | AN0025 and Pembrolizumab Combination in Advanced Solid Tumors | unknown | Phase 1 | 63 | Adlai Nortye Biopharma Co., Ltd.INDUSTRY | 2 | Jun 27, 2024 | clinicaltrials |
| NCT06428708 | [18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma | unknown | Early Phase 1 | 30 | Western UniversityOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT05500846 | Targeted Cryoablation of Prostate Cancer Lesions: An Investigator-initiated Trial(PROCRY) | unknown | N/A | 51 | Osamu UkimuraOTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT06468254 | An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer | unknown | Phase 2 | 500 | Anhui Provincial Cancer HospitalOTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT06018935 | A Cohort Establishment Study of Total Management of Ovarian Cancer | unknown | — | 500 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | Jun 20, 2024 | clinicaltrials |
| NCT06427993 | Urine DNA Methylation Detection for Hematuria Evaluation | unknown | — | 71 | Changhai HospitalOTHER | 1 | Jun 20, 2024 | clinicaltrials |
| NCT05155618 | Intervention Study in Prostate Cancer Patients Undergoing Radiotherapy(MicroStyle) | unknown | N/A | 311 | European Institute of OncologyOTHER | 1 | Jun 18, 2024 | clinicaltrials |
| NCT06462495 | Head-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET/CT in PCa Diagnosis, Recurrence, and Metastasis | unknown | Early Phase 1 | 30 | Anhui Provincial HospitalOTHER_GOV | 1 | Jun 17, 2024 | clinicaltrials |
| NCT06462508 | Head-to-head Comparison of [18F]F-PSMA-N5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis | unknown | Early Phase 1 | 30 | Anhui Provincial HospitalOTHER_GOV | 1 | Jun 17, 2024 | clinicaltrials |
| NCT02042807 | To Evaluate the Effect of MCS® in Prostate Cancer Prevention(MCS-8) | unknown | Phase 2 | 702 | Health Ever Bio-Tech Co., Ltd.INDUSTRY | 1 | Jun 13, 2024 | clinicaltrials |
| NCT06455072 | Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer | unknown | Phase 2 | 37 | Fujian Cancer HospitalOTHER_GOV | 1 | Jun 12, 2024 | clinicaltrials |
| NCT05607602 | Are Uterine Fibroids Pro-thrombotic? | unknown | — | 105 | King's College Hospital NHS TrustOTHER | 1 | Jun 11, 2024 | clinicaltrials |
| NCT06293066 | Performance of Ultrasound in Women With Postmenopausal or Abnormal Uterine Bleeding Between White and Black Ethnic Groups- a Retrospective Cohort Study. | unknown | — | 330 | King's College Hospital NHS TrustOTHER | 1 | Jun 11, 2024 | clinicaltrials |
| NCT06448897 | Development of an Imaging Prediction Model for Pelvic Lymph Node Metastasis of Cervical Cancer Using Artificial Intelligence Techniques. | unknown | — | 4,000 | Obstetrics & Gynecology Hospital of Fudan UniversityOTHER | 1 | Jun 7, 2024 | clinicaltrials |
| NCT06445621 | Early Detection of Relapse in Ovarian Cancer Using Capillary Home-sampling and a Protein Biomarker Test(FOLL-OV) | unknown | — | 125 | Uppsala University HospitalOTHER | 1 | Jun 6, 2024 | clinicaltrials |
| NCT06424080 | Oncological and Perioperative Outcomes of Laparoscopic Versus Robotic Partial Nephrectomy for Treatment of Renal Tumors. | unknown | N/A | 20 | Menoufia UniversityOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT06441292 | Multi-Modal Image Fusion for Precision Prostate Biopsy Navigation | unknown | N/A | 602 | Shanghai East HospitalOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT06250010 | Immunotolerance in Endometrial Cancer and at the Maternal-fetal Interface: Immunological Profiling of the Tumor Microenvironment in Risk Stratification of Recurrence | unknown | — | 30 | Regina Elena Cancer InstituteOTHER | 1 | May 31, 2024 | clinicaltrials |
| NCT06437496 | 68Ga-AAZTA-093 PET/CT: First-in-human Study | unknown | Early Phase 1 | 30 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | May 31, 2024 | clinicaltrials |
| NCT06431724 | A Review of Cervical Cancer Screening Practices in Women Age >65 | unknown | — | 300 | Sarasota Memorial Health Care SystemOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT06429878 | The Long Term Effect of MRI Before Radical Prostatectomy. | unknown | N/A | 438 | Oslo University HospitalOTHER | 0 | May 28, 2024 | clinicaltrials |
| NCT05799248 | Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management | unknown | Phase 3 | 113 | MidLantic UrologyOTHER | 1 | May 24, 2024 | clinicaltrials |
Data updated 22 days agoSource updated Aug 5, 2024source: clinicaltrials